Mayo Clinic Talks cover image

Mild Cognitive Impairment

Mayo Clinic Talks

00:00

GLP‑1 Agonists and Ongoing Trials

Dr. Petersen describes large semaglutide trials in amyloid‑positive patients and potential anti‑inflammatory benefits beyond amyloid/tau targeting.

Play episode from 28:21
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app